Sort
40,608 grants matching “prostate cancer”
OPTIMIZING TREATMENT OF ADVANCED PROSTATE CANCER AND EXPLOITING MECHANISMS DRIVING CASTRATION RESISTANCE
$396,000Fred Hutchinson Cancer Research Center · · FY2010 · Department of the Army
Role of GATA2 signaling network in Lethal Prostate Cancer
$395,976Josep Maria Domingo-Domenech · Thomas Jefferson University · R01 · FY2020 · CA
ADMINISTRATIVE CORE
$395,974Cimona V Hinton · Clark Atlanta University · U54 · FY2024 · MD
Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte
$395,910John A. Petros · Cedars-Sinai Medical Center · P01 · FY2010 · CA
Identification of Small Molecule Inhibitors of QSOX1
$395,880Sergei Svarovsky · Sapphire Biotech, Inc. · R43 · FY2020 · CA
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival
$395,877Peter S Nelson · Beth Israel Deaconess Medical Center · P01 · FY2023 · CA
Sequence-specific Hybridization Capture for Discovery of ProteoformâlncRNA Interactions in Prostate Cancer
$395,773Lloyd M Smith · University Of Wisconsin-Madison · R01 · FY2021 · CA
Characterizing the signaling pathways that regulate Skp2 oncogenic function
$395,738Wenyi Wei · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Characterizing the signaling pathways that regulate Skp2 oncogenic function
$395,738Wenyi Wei · Beth Israel Deaconess Medical Center · R01 · FY2016 · CA
Characterizing the signaling pathways that regulate Skp2 oncogenic function
$395,738Wenyi Wei · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Characterizing the signaling pathways that regulate Skp2 oncogenic function
$395,738Wenyi Wei · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA
Investigating Abbapolin PLK1 Polo Box Domain inhibitors as potential therapeutics for colorectal cancers
$395,724Campbell McInnes · Ppi Pharmaceuticals, Llc · R41 · FY2025 · CA
Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology
$395,714Ming Hui Chen · Duke University · R01 · FY2024 · CA
Telomerase RNA Transfected Dendritic Cell Vaccines
$395,707Duke University · R01 · FY2003 · CA
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival
$395,702Peter S Nelson · Beth Israel Deaconess Medical Center · P01 · FY2022 · CA
Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
$395,685Liangzhong Shawn Xiang · University Of California-Irvine · R37 · FY2025 · CA
Developing therapies to improve enzalutamide in CRPC
$395,685Zheng David Qian · Oregon Health & Science University · R01 · FY2024 · CA
Dynamic Metabolic Imaging of Hyperpolarized Substrates
$395,659Dirk Mayer · Sri International · R01 · FY2010 · EB
LABOR MARKET OUTCOMES OF LONG TERM CANCER SURVIVORS
$395,652Michigan State University · R01 · FY2002 · CA
Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort
$395,636Lorelei Mucci · Harvard School Of Public Health · R01 · FY2018 · CA
HIGH-FIELD ANIMAL MRI: BREAST &PROSTATE CANCER
$395,600University Of Maryland Baltimore · S10 · FY2005 · RR
University of Maryland Greenebaum Cancer Center Support Grant
$395,573Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2015 · CA
Hyaluronan Receptors in Prostate Cancer Progression
$395,561James B. McCarthy · University Of Minnesota · R01 · FY2008 · CA
Mechanisms of Testosterone Action
$395,536Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2013 · AG
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer
$395,515Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA